![Helen Sabzevari](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Sabzevari
Directeur Général chez
PRECIGEN, INC.
Fortune : 24 M $ au 31/07/2026
Profil
Helen Sabzevari was the founder and Chief Scientific Officer at Compass Therapeutics LLC, which was founded in 2015.
She held this position from 2015 to 2017.
She is currently the President, Chief Executive Officer & Director at Precigen, Inc. since 2020 and the President at PGEN Therapeutics, Inc. since 2017.
Dr. Sabzevari has also served as an Independent Director at Kinnate Biopharma, Inc. from 2021 to 2024.
In addition, she was the Senior Vice President-Health Therapeutics at Precigen, Inc. in 2017 and the Global Head-Immunotherapy, Oncology & Research at EMD Serono, Inc. from 2008 to 2014.
Dr. Sabzevari holds a doctorate degree from The Scripps Research Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRECIGEN INC 1,26 % | 29/06/2026 | 3 768 872 ( 1,26 % ) | 24 M $ | 31/07/2026 |
Postes actifs de Helen Sabzevari
| Sociétés | Poste | Début |
|---|---|---|
| PRECIGEN, INC. | Directeur Général | 01/01/2020 |
PGEN Therapeutics, Inc.
 PGEN Therapeutics, Inc. BiotechnologyHealth Technology Develops gene and cellular therapies | President | 01/11/2017 |
Anciens postes connus de Helen Sabzevari
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Directeur/Membre du Conseil | 03/04/2024 |
| PRECIGEN, INC. | Corporate Officer/Principal | 01/11/2017 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Fondateur | 01/01/2017 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Directeur Technique/Scientifique/R&D | 01/01/2014 |
Formation de Helen Sabzevari
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
PGEN Therapeutics, Inc.
PGEN Therapeutics, Inc. BiotechnologyHealth Technology Develops gene and cellular therapies | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
